Finance

Biotechs Soar After Big Trump Drug Price Speech- Mid-Caps Should

Biotechs Soar And Find Relief After Trump Big Speech Look to MId-Caps for Momentum Large Caps are Value Stocks Gene Editing and Gene Therapy Provides New Theme Biotechs soared Friday immediately after Trump’s much-anticipated new drug plan speech which was going to address high drug prices and potentially bring more government intervention. The big concern…

Play An Accordion: Go To Jail

That’s the law. OK, maybe not (unless you take all your legal counsel from bumper stickers). But there does seem to be one market law these days, which is that on those rare occasions when selling is allowed to take place, the S&P 500 shall go NO LOWER than its 200-day exponential moving average. Keep this…

Technical Market Report

The good news is: The secondaries outperformed the blue chips again last week. The Negatives The market is overbought. The Dow Jones Industrial Average (DJIA) has been up for 7 consecutive days and the Russell 2000 (R2K) has been up for 6 consecutive days. Seasonality for the coming week has been, on average, negative. The…

If ZTE Sanctions Are Up For Grabs, What About Additional Section

Economic policy uncertainty as measured by the Baker, Bloom and Davis index is elevated (again) due to trade policy. Figure 1: US Economic Policy Uncertainty index (blue) and centered 7-day moving average (bold red). Source: policyuncertainty.com accessed 14 May 2018, and author’s calculations. Does this uncertainty matter? This article addressing just the Section 232 sanctions suggests the answer is “yes” (I must…